Functional domains of the BACE1 and BACE2 promoters and mechanisms of transcriptional suppression of the BACE2 promoter in normal neuronal cells

Journal of Molecular Neuroscience

Volumn 29, Issue 1, 2006, Pages 65-80

  Lahiri, Debomoy K ^a   Maloney, Bryan ^a   Ge, Yuan Wen ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Amyloid; Dementia; Neurons; Promoter; Secretase; Transcription factors

Indexed keywords

ASPARTIC PROTEINASE; BETA SECRETASE; BETA SECRETASE 2; CCAAT BINDING FACTOR; GAMMA SECRETASE; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYO; GENE CONTROL; GENE SEQUENCE; HUMAN; HUMAN CELL; MOUSE; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; RAT; REPORTER GENE; TANDEM REPEAT; TATA BOX; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; ASPARTIC ENDOPEPTIDASES; BASE SEQUENCE; CELL LINE; CHROMOSOME MAPPING; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MOLECULAR SEQUENCE DATA; NEURONS; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; RATS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; XENOPUS LAEVIS; ZEBRAFISH;

EID: 33646896068     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:29:1:65     Document Type: Article

References (49)

1. Acquati F., Accarino M., Nucci C., Fumagalli P., Jovine L., Ottolenghi S., and Taramelli R. (2000) The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region. FEBS Lett. 468, 59-64.
2. Basi G., Frigon N., Barbour R., Doan T., Gordon G., McConlogue L., et al. (2003) Antagonistic effects of β-site amyloid precursor protein-cleaving enzymes 1 and 2 on β-amyloid peptide production in cells. J. Biol Chem. 278, 31,512-31,520.
3. Bennett B. D., Babu-Khan S., Loeloff R., Louis J. C., Curran E., Citron M., and Vassar R. (2000) Expression analysis of BACE2 in brain and peripheral tissues. J. Biol. Chem. 275, 20,647-20,651.
4. Benson D. A., Karsch-Mizrachi I., Lipman D. J., Ostell J., and Wheeler D. L. (2005) GenBank. Nucleic Acids Res. 33, D34-38.
5. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
6. Cady C., Evans M. S., and Brewer G. J. (2001) Age-related differences in NMDA responses in cultured rat hippocampal neurons. Brain Res. 921, 1-11.
7. Carrodeguas J. A., Rodolosse A., Garza M. V., Sanz-Clemente A., Perez-Pe R., Lacosta A. M., et al. (2005) The chick embryo appears as a natural model for research in β-amyloid precursor protein processing. Neuroscience 134, 1285-1300.
8. Chen Q. Y. and Jackson N. (2004) Human CD1D gene has TATA boxless dual promoters: an SP1-binding element determines the function of the proximal promoter. J. Immunol. 172, 5512-5521.
9. Christensen M. A., Zhou W., Qing H., Lehman A., Philipsen S., and Song W. (2004) Transcriptional regulation of BACE1, the β-amyloid precursor protein β-secretase, by Sp1. Mol. Cell. Biol. 24, 865-874.
10. Corpet F. (1988) Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16, 10,881-10,890.
11. Farzan M., Schnitzler C. E., Vasilieva N., Leung D., and Choe H. (2000) BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein. Proc. Natl. Acad. Sci. U. S. A. 97, 9712-9717.
12. Ge Y. W., Maloney B., Sambamurti K., and Lahiri D. K. (2004) Functional characterization of the 5′ flanking region of the BACE gene: identification of a 91 bp fragment involved in basal level of BACE promoter expression. FASEB J. 18, 1037-1039.
13. Ghosh C., Song W., and Lahiri D. K. (2000) Efficient DNA transfection in neuronal and astrocytic cell lines. Mol. Biol. Rep. 27, 113-121.
14. Girish V. and Vijayalakshmi A. (2004) Affordable image analysis using NIH Image/ImageJ. Indian J. Cancer 41, 47.
15. Hardy J. and Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
16. Hussain I., Powell D., Howlett D. R., Tew D. G., Meek T. D., Chapman C., et al. (1999) Identification of a novel aspartic protease (Asp 2) as β-secretase. Mol. Cell. Neurosci. 14, 419-427.
17. Ikeo K., Takahashi K., and Gojobori T. (1992) Evolutionary origin of a Kunitz-type trypsin inhibitor domain inserted in the amyloid β precursor protein of Alzheimer's disease. J. Mol. Evol. 34, 536-543.
18. Jurka J., Klonowski P., Dagman V., and Pelton P. (1996) CENSOR - a program for identification and elimination of repetitive elements from DNA sequences. Comput. Chem. 20, 119-121.
19. Kim C. S., Hwang C. K., Choi H. S., Song K. Y., Law P. Y., Wei L. N., and Loh H. H. (2004) Neuron-restrictive silencer factor (NRSF) functions as a represser in neuronal cells to regulate the mu opioid receptor gene. J. Biol. Chem. 279, 46,464-46,473.
20. Kitami Y., Fukuoka T., Okura T., Takata Y., Maguchi M., Igase M., et al. (1998) Molecular structure and function of rat platelet-derived growth factor β-receptor gene promoter. J. Hypertens. 16, 437-445.
21. Kitami Y., Maguchi M., Nishida W., Okura T., Kohara K., and Hiwada K. (1999) The unique 5′-flanking region of the human basic calponin gene. Hypertens. Res. 22, 187-193.
22. Klein S. L., Strausberg R. L., Wagner L., Pontius J., Clifton S. W., and Richardson P. (2002) Genetic and genomic tools for Xenopus research: The NIH Xenopus initiative. Dev. Dyn. 225, 384-391.
23. Kong A., Gudbjartsson D. F., Sainz J., Jonsdottir G. M., Gudjonsson S. A., Richardsson B., et al. (2002) A high-resolution recombination map of the human genome. Nat. Genet. 31, 241-247.
24. Lahiri D. K., Alley G. M., Ge Y. W., and Du Y. (2002) Functional characterization of the 5′-regulatory region of the murine apolipoprotein gene. Ann. N. Y. Acad. Sci. 973, 340-344.
25. Lahiri D. K. and Ge Y. (2000) Electrophoretic mobility shift assay for the detection of specific DNA-protein complex in nuclear extracts from the cultured cells and frozen autopsy human brain tissue. Brain Res. Brain Res. Protoc. 5, 257-265.
26. Lahiri D. K., Farlow M. R., Sambamurti K., Greig N. H., Giacobini E., and Schneider L. S. (2003) A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr. Drug Targets 4, 97-112.
27. Lahiri D. K., Ge Y.-W., and Maloney B. (2005a) Characterization of the APP proximal promoter and 5′-untranslated regions: identification of cell-type specific domains and implications in APP gene expression and Alzheimer's disease. FASEB J. 19, 653-655.
28. Lahiri D. K., Maloney B., and Ge Y.-W. (2006) BACE1 gene promoter is differentially regulated: detection of a novel promoter region for its cell type-specific regulation. J. Mol. Neurosci., in press.
29. Lahiri D. K., Nall C., and Ge Y. W. (1999) Promoter activity of the β-amyloid precursor protein gene is negatively modulated by an upstream regulatory element. Brain Res. Mol. Brain Res. 71, 32-41.
30. Lahiri D. K., Sambamurti K., and Bennett D. A. (2004) Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease. Neurobiol. Aging 25, 651-660.
31. Lahiri D. K., Wavrant De-Vrieze F., Ge Y.-W., Maloney B., and Hardy J. (2005b) Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease. Neurobiol. Aging 26, 1329-1341.
32. Li Y. P. and Chen W. (1999) Characterization of mouse cathepsin K gene, the gene promoter, and the gene expression. J. Bone Miner. Res. 14, 487-499.
33. Lin X., Koelsch G., Wu S., Downs D., Dashti A., and Tang J. (2000) Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein. Proc. Natl. Acad. Sci. U. S. A. 97, 1456-1460.
34. Long J. A. and Gordon M. S. (2004) The greatest step in vertebrate history: a paleobiological review of the fish-tetrapod transition. Physiol. Biochem. Zool. 77, 700-719.
35. Maloney B., Ge Y.-W., and Lahiri D. K. (2006) Structural and functional characterization of the human β-secretase 2 (BACE2) 5′-flanking region: identification of a 268-kb region as the basal BACE2 promoter. J. Mol. Neurosci., this issue.
36. Maloney B., Ge Y.-W., Greig N., and Lahiri D. K. (2004) Presence of a "CAGA box" in the APP gene unique to amyloid plaque-forming species and absent in all APLP-1/2 genes: implications in Alzheimer's disease. FASEB J. 18, 1288-1290.
37. Neve R. L., McPhie D. L., and Chen Y. (2001) Alzheimer's disease: dysfunction of a signalling pathway mediated by the amyloid precursor protein? Biochem. Soc. Symp. 37-50.
38. Pruitt K. D., Tatusova T., and Maglott D. R. (2005) NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 33, D501-D504.
39. Sambamurti K., Kinsey R., Maloney B., Ge Y.-W., and Lahiri D. K. (2004) Gene structure and organization of the human β-secretase (BACE) promoter. FASEB J. 18, 1034-1036.
40. Schoenherr C. J. and Anderson D. J. (1995) The neuronrestrictive silencer factor (NRSF): a coordinate represser of multiple neuron-specific genes. Science 267, 1360-1363.
41. Solans A., Estivill X., and de la Luna S. (2000) A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer's amyloid precursor protein β-secretase. Cytogenet. Cell Genet. 89, 177-184.
42. Song W. and Lahiri D. K. (1998) Molecular cloning of the promoter of the gene encoding the Rhesus monkey β-amyloid precursor protein: structural characterization and a comparative study with other species. Gene 217, 151-164.
43. Stamatoyannopoulos J. A. (2004) The genomics of gene expression. Genomics 84, 449-457.
44. Sun X., Wang Y., Qing H., Christensen M. A., Liu Y., Zhou W., et al. (2005) Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes. FASEB J. 19, 739-749.
45. Vassar R., Bennett B. D., Babu-Khan S., Kahn S., Mendiaz E. A., Denis P., et al. (1999) β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
46. Waisman A., Aloni Y., and Laub O. (1990) In vitro regulation of human hepatitis B virus core gene transcription. Virology 177, 737-744.
47. Xie J., Roddy P., Rife T. K., Murad F., and Young A. P. (1995) Two closely linked but separable promoters for human neuronal nitric oxide synthase gene transcription. Proc. Natl. Acad. Sci. U. S. A. 92, 1242-1246.
48. Yan R., Bienkowski M. J., Shuck M. E., Miao H., Tory M. C., Pauley A. M., et al. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity. Nature 402, 533-537.
49. Yan R., Munzner J. B., Shuck M. E., and Bienkowski M. J. (2001) BACE2 functions as an alternative α-secretase in cells. J. Biol. Chem. 276, 34,019-34,027.